Sorghum extract exerts an anti-diabetic effect by improving insulin sensitivity via PPAR-γ in mice fed a high-fat diet
1
조회
0
다운로드
6
인용
0
참고문헌
키워드
초록
This study investigated the hypothesis that a sorghum extract exerts anti-diabetic effects through a mechanism that improves insulin sensitivity via peroxisome proliferator-activated receptor gamma (PPAR-γ) from adipose tissue. Seven C57BL/6 mice were fed an AIN-93M diet with fat consisting of 10% of total energy intake (LF) for 14 weeks, and 21 mice were fed a high-fat AIN diet with 60% of calories derived from fat (HF). From week 8, the HF diet-fed mice were orally administered either saline (HF group), 0.5% (0.5% SE group), or 1% sorghum extract (1% SE group)for 6 weeks (n = 7/group). Perirenal fat content was significantly lower in the 0.5% SE and 1% SE groups than that in the HF mice. Levels of total and low-density lipoprotein cholesterol, triglycerides, glucose, and the area under the curve for glucose were significantly lower in mice administered 0.5% SE and 1% SE than those in HF mice. Serum insulin level was significantly lower in mice administered 1% SE than that in HF mice or those given 0.5% SE. PPAR-γ expression was significantly higher, whereas the expression of tumor necrosis factor-α was significantly lower in mice given 1% SE compared to those in the HF mice. Adiponectin expression was also significantly higher in mice given 0.5% SE and 1% SE than that in the HF mice. These results suggest that the hypoglycemic effect of SE may be related with the regulation of PPAR-γ-mediated metabolism in this mouse model.
Abstract
This study investigated the hypothesis that a sorghum extract exerts anti-diabetic effects through a mechanism that improves insulin sensitivity via peroxisome proliferator-activated receptor gamma (PPAR-γ) from adipose tissue. Seven C57BL/6 mice were fed an AIN-93M diet with fat consisting of 10% of total energy intake (LF) for 14 weeks, and 21 mice were fed a high-fat AIN diet with 60% of calories derived from fat (HF). From week 8, the HF diet-fed mice were orally administered either saline (HF group), 0.5% (0.5% SE group), or 1% sorghum extract (1% SE group)for 6 weeks (n = 7/group). Perirenal fat content was significantly lower in the 0.5% SE and 1% SE groups than that in the HF mice. Levels of total and low-density lipoprotein cholesterol, triglycerides, glucose, and the area under the curve for glucose were significantly lower in mice administered 0.5% SE and 1% SE than those in HF mice. Serum insulin level was significantly lower in mice administered 1% SE than that in HF mice or those given 0.5% SE. PPAR-γ expression was significantly higher, whereas the expression of tumor necrosis factor-α was significantly lower in mice given 1% SE compared to those in the HF mice. Adiponectin expression was also significantly higher in mice given 0.5% SE and 1% SE than that in the HF mice. These results suggest that the hypoglycemic effect of SE may be related with the regulation of PPAR-γ-mediated metabolism in this mouse model.
참고문헌 (33)
- Craig ME, "Definition, epidemiology and classification of diabetes in children and adolescents", Pediatr Diabetes, 10(Suppl 12), pp.3~12 (2009)
- Agius L., "New hepatic targets for glycaemic control in diabetes", Best Pract Res Clin Endocrinol Metab, 21, pp.587~605 (2007)
- Hotamisligil GS, "The role of TNFalpha and TNF receptors in obesity and insulin resistance", J Intern Med, 245, pp.621~625 (1999)
- Yamauchi T, "The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity", Nat Med, 7, pp.941~946 (2001)
- Maeda N, "PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein", Diabetes, 50, pp.2094~2099 (2001)
- Lehmann JM, "An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)", J Biol Chem, 270, pp.12953~12956 (1995)
- Bouskila M, "Adiponectin: a relevant player in PPARgamma-agonist-mediated improvements in hepatic insulin sensitivity?", Int J Obes (Lond), 29(Suppl 1), pp.17~23 (2005)
- Spranger J, "Adiponectin and protection against type 2 diabetes mellitus", Lancet, 361, pp.226~228 (2003)
- Hotamisligil GS, "Increased adipose tissue expression of tumor necrosis factoralpha in human obesity and insulin resistance", J Clin Invest, 95, pp.2409~2415 (1995)
- "FAOSTAT Database"[URL]
- Kamath VG, "Antiradical properties of sorghum (Sorghum bicolor L. Moench) flour extracts", J Cereal Sci, 40, pp.283~288 (2004)
- Sikwese FE, "Antioxidant effect of a crude phenolic extract from sorghum bran in sunflower oil in the presence of ferric ions", Food Chem, 104, pp.324~331 (2007)
- 박미영, "Hog millet (Panicum miliaceum L.)-supplemented diet ameliorates hyperlipidemia and hepatic lipid accumulation in C57BL", 6J-ob, Nutrition Research and Practice, pp.2011, 5(6)[DOI]
- Carr TP, "Grain sorghum lipid extract reduces cholesterol absorption and plasma non-HDL cholesterol concentration in hamsters", J Nutr, 135, pp.2236~2240 (2005)
- Hoi JT, "Sorghum distillers dried grain lipid extract increases cholesterol excretion and decreases plasma and liver cholesterol concentration in hamsters", J Funct Foods, 1, pp.381~386 (2009)
- van Rensburg SJ, "Epidemiologic and dietary evidence for a specific nutritional predisposition to esophageal cancer", J Natl Cancer Inst, 67, pp.243~251 (1981)
- Yeo MA, "Antidiabetic effects of three Korean sorghum phenolic extracts in normal and streptozotocin-induced diabetic rats", FOOD RESEARCH INTERNATIONAL, 44(1), pp.127~132 (2011), ELSEVIER SCIENCE BV
- Yeo MA, "Antilipidemic activity of organic solvent extract from Sorghum bicolor on rats with diet-induced obesity", HUMAN EXPERIMENTAL TOXICOLOGY, 30(11), pp.1865~1868 (2011), SAGE PUBLICATIONS LTD
- Friedewald WT, "Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge", Clin Chem, 18, pp.499~502 (1972)
- Kim JS, "The inhibitory effects of ethanol extracts from sorghum, foxtail millet and proso millet on α -glucosidase and α-amylase activities", Food Chem, 124, pp.1647~1651 (2011)
- Ruzaidi A, "The effect of Malaysian cocoa extract on glucose levels and lipid profiles in diabetic rats", J Ethnopharmacol, 98, pp.55~60 (2005)
- Akase T, "Preventive effects of Salacia reticulata on obesity and metabolic disorders in TSOD mice", Evid Based Complement Alternat Med, 2011, pp.484590~ (2011)
- Lakshmi KB, "Hypoglycemic effect of selected sorghum recipes", Nutr Res, 16, pp.1651~1658 (1996)
- Ray TK, "Long-term effects of dietary fiber on glucose tolerance and gastric emptying in noninsulin-dependent diabetic patients", Am J Clin Nutr, 37, pp.376~381 (1983)
- Lee SH, "Millet consumption decreased serum concentration of triglyceride and C-reactive protein but not oxidative status in hyperlipidemic rats", Nutr Res, 30, pp.290~296 (2010)
- Chawla A, "Peroxisome proliferator-activated receptor (PPAR) gamma: adiposepredominant expression and induction early in adipocyte differentiation", Endocrinology, 135, pp.798~800 (1994)
- Tontonoz P, "Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor", Cell, 79, pp.1147~1156 (1994)
- Willson TM, "The PPARs: from orphan receptors to drug discovery", J Med Chem, 43, pp.527~550 (2000)
- Arner P, "The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones", Trends Endocrinol Metab, 14, pp.137~145 (2003)
- Thamer C, "Relationship between serum adiponectin concentration and intramyocellular lipid stores in humans", Horm Metab Res, 34, pp.646~649 (2002)
- Bursill CA, "A green tea extract lowers plasma cholesterol by inhibiting cholesterol synthesis and upregulating the LDL receptor in the cholesterol-fed rabbit", Atherosclerosis, 193, pp.86~93 (2007)
- Singh DK, "Green and black tea extracts inhibit HMG-CoA reductase and activate AMP kinase to decrease cholesterol synthesis in hepatoma cells", J Nutr Biochem, 20, pp.816~822 (2009)
- Maron DJ, "Cholesterol-lowering effect of a theaflavin-enriched green tea extract: a randomized controlled trial", Arch Intern Med, 163, pp.1448~1453 (2003)